Refine by
Industries served
- Medical / Health Care
- Agriculture
- Energy
- Monitoring and Testing
- Water and Wastewater
- Environmental
- Chemical & Pharmaceuticals
- Manufacturing, Other
- Oil, Gas & Refineries
- Health and Safety
- Electronics and Computers
- Air and Climate
- Aerospace & Air Transport
- Metal
- Mining
- University / Academia / Research
- Plastics & Resins
- Waste and Recycling
- Construction & Construction Materials
- Automobile & Ground Transport
- Banking & Finance / Insurance / Legal
- Defense
- Commercial
- Logistics
- Paint
- Communications / Telecom / Datacom
- Soil and Groundwater
- Government
- Food and Beverage
- Furniture
- Dry Cleaning
- Domestic
- Forestry & Wood
- Glassware
- Packaging
- Leather & Tanning
- Printing
- Textile
Medical Industry Technology Serving Andorra
330 companies found
Premium
Technologybased inRignano S.Arno (Firenze), ITALY
C&G Evaporator is the leading company in the design and production of vacuum evaporators. Water is life, and far too precious a resource to be wasted. We know this well at C&G Evaporator, which is why we create solutions capable of significantly ...
Technologybased inEdinburgh, UNITED KINGDOM
Extra-corporeal treatments like dialysis, cardiopulmonary bypass, and ECMO involve the circulation of the patient's blood supply through a machine. The patient's immune system treats the machine as a large, unwanted foreign body; the resulting ...
Before a patient can start an extra-corporeal treatment, like dialysis and cardiopulmonary bypass, the extra-corporeal circuit must be primed. This involves flushing the circuit with saline, or similar solutions, to remove air and any particulates, ...
Technologybased inFrankfurt am Main, GERMANY
We are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses ...
Cardiotoxicity is a growing issue in Oncology: cardio-oncology is an emerging discipline focused predominantly on the detection and management of cancer treatment-induced cardiac dysfunction (cardiotoxicity). Around 20% of all cancer survivors will ...
Technologybased inYongin-si, SOUTH KOREA
Vivozon is a global innovative drug development company established in 2008. We built an efficacy-based new drug discovery system that is clearly distinct from the existing new drug development paradigm, and discovered the non- narcotic analgesic ...
Opiranserin (VVZ-149) for injection is a first-in-class non-narcotic analgesic under development by Vivozon. As atreatment for postoperative pain used as a first-line therapy in the global market, Opiranserin aims to ultimately replaceopioid ...
Technologybased inNew York, NEW YORK (USA)
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...
Technologybased inDallas, TEXAS (USA)
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology ...
Our Vaxxine Platform is designed to harness the immune system to convert the body into its own natural “drug factory” stimulating the production of antibodies. Our technology uses synthetic peptides to mimic and optimally combine ...
Technologybased inVienna, AUSTRIA
Hookipa Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our non-replicating and ...
Our scientific platform includes two distinct approaches to arenavirus-based therapies: replicating and non-replicating. Our replicating technology is designed to create a stronger immune response that we believe is more appropriate for use in ...
Technologybased inBoston, MASSACHUSETTS (USA)
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...
We’re investigating a portfolio of other small molecule medicines aimed at treating the underlying cause of CF. This includes CFTR potentiators, which are designed to keep CFTR proteins at the cell surface open longer to improve the flow of ...
Technologybased inToronto, ONTARIO (CANADA)
uFluidix is industry leader in custom fabrication of Microfluidic devices made of PDMS and thermoplastics. uFluidix owns and operates its own highly confidential cleanroom production facilities for Microfluidics fully equipped by state of the art ...
Technologybased inCarlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
The next generation CORE-NK platform will integrate additional activation and expansion features to further optimize the cancer-fighting power of the CORE-NK platform cells. Development of the next generation CORE-NK platform will be as a ...
Technologybased inDresden, GERMANY
PharmAI’s mission is to make early-stage drug discovery far more efficient by increasing success rates while reducing costs. The company develops groundbreaking AI-powered software for the analysis of 3D protein structures. This technology helps ...
pharmAI's innovative solution, which is based on analysing the binding sites, decreases the screening space dramatically. pharmAIs algorithms provide the drug developers with predictions of one or multiple constrained compound space(s) that can ...
Technologybased inAtlanta, GEORGIA (US) (USA)
Hypercell has developed a proprietary point-of-care diagnostic technology platform that is as accurate as the gold standard PCR, 10x faster, and without expensive lab equipment. Hypercell allows the detection of biological contaminants in the food ...
Hypercell Allows Stakeholders Along The Entire Food Chain To Rapidly Identify, Manage And Respond To Biological ...
Technologybased inNess Ziona, ISRAEL
At Luxembourg Bio Technologies, we specialize in providing products to address your peptide synthesis needs. Many of our coupling reagents, especially our proprietary products, are designed to provide maximum yield with minimal racemization. We are ...
PyOxim® is a novel and highly efficient coupling reagent that mediates coupling reactions with efficiencies superior to HATU and PyBOP® and comparable to COMU®. CAS: 153433-21-7. ...
Technologybased inDavis, CALIFORNIA (USA)
Headquartered in Davis, California, Expression Systems is dedicated to supplying and servicing the baculovirus, cell culture and bio-industrial markets with innovative media formulations, complementary products and contract services. We specialize ...
Expression Systems’ contract production services can assist you at any step of the process, solving technical problems in molecular biology, purification or other issues relating to BEVS. ...
Technologybased inSaint John, NEW BRUNSWICK (CANADA)
ARC Clean Technology is a Canadian clean energy company focused on providing affordable, carbon-free energy solutions, particularly through their advanced small modular reactor called the ARC-100. This technology aims to deliver safe, reliable, and ...
Technologybased inAtlanta, GEORGIA (US) (USA)
Carestream Dental is committed to transforming dentistry, simplifying technology and changing lives. In this pursuit, we focus on providing cloud solutions and technology for practice and clinical management for dental practices, groups, DSOs and ...
Bite blocks for Carestream Dental's extraoral imaging equipment. Multiple options ...
Technologybased inNew Market, MARYLAND (USA)
FiberCell Systems specializes in innovative cell culture technology, offering advanced solutions for a wide array of applications, including the production of recombinant proteins, monoclonal antibodies, antibiotic pharmacokinetics/pharmacodynamics ...
0.1 µm pore size for the highest exchange rates but without protein retention. 80 cm2 outer surface area. PVDF fiber allow for the attachment of matrix proteins, cytokines and antibodies. Ideal fiber for endothelial cell culture under ...
Technologybased inSuwon, SOUTH KOREA
Onegene Biotechnology develops transformative therapeutics for the chronic and complex diseases. Our UniStac platform allows rationale-based design of multispecific drug in true plug-and-play ...
OGB23501 is a first-in-class tri-specific tumor microenvironment (TME) immune activator, which simultaneously targets PD-1, CTLA-4, and VEGF. We aim to develop it as a potential backbone therapy for melanoma, NSCLC, HCC, and renal ...
Technologybased inLivermore, CALIFORNIA (USA)
Advanced Bifurcation Systems has disruptive technology for left main heart disease, stenting coronary arteries at their branch points. This platform is a paradigm shift in interventional cardiology. The ABS platform is protected by more than 36 ...
Current dedicated “bifurcation stent” systems are either side-branch stents or main branch stents with a side-hole, used in a “side-branch first” or “main-branch first” deployment ...
Technologybased inCopenhagen V, DENMARK
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. We are led by an experienced ...
DuoBody-CD40x4-1BB (GEN1042) is a proprietary bispecific antibody, jointly owned by Genmab and BioNTech, created using Genmab’s DuoBody® technology. It is being co-developed under an agreement in which the companies share all costs and ...
